Infrequent alterations of the p15, p16, CDK4 and cyclin D1 genes in non-astrocytic human brain tumors.

作者: Kazufumi Sato , Barbara Schäuble , Paul Kleihues , Hiroko Ohgaki , None

DOI: 10.1002/(SICI)1097-0215(19960503)66:3<305::AID-IJC6>3.0.CO;2-2

关键词: GliomaExonCancer researchGeneBiologySouthern blotCyclin D1Neuroectodermal tumorTumor suppressor geneOligodendroglioma

摘要: While several genetic alterations associated with the evolution of astrocytomas have been identified, molecular basis non-astrocytic brain tumors has remained largely unknown. In this study, p15, p16, CDK4 and cyclin D1 genes were analyzed in 69 nonastrocytic human tumors, including 17 oligodendrogliomas, 16 medulloblastomas/primitive neuroectodermal (PNETs), 14 ependymomas 22 meningiomas. Southern blot analysis DNA from frozen samples showed no homozygous deletions p15 or p16 any these tumors. No mobility shift was found by PCR-single-strand conformation polymorphism (PCR-SSCP) exons 1 2 gene genes, except for one oligodendroglioma. Direct sequencing tumor a G A transition at nucleotide 436 (codon 140) exon gene, which is common polymorphism. analyses revealed amplification neoplasms analyzed. contrast to astrocytic show frequent loss alteration appears be rare other nervous system. © 1996 Wiley-Liss, Inc.

参考文章(29)
G Reifenberger, K Ichimura, V P Collins, E E Schmidt, CDKN2 (p16/MTS1) gene deletion or CDK4 amplification occurs in the majority of glioblastomas. Cancer Research. ,vol. 54, pp. 6321- 6324 ,(1994)
Jin Jen, J Wade Harper, Sandra H Bigner, Darell D Bigner, Nickolas Papadopoulos, Sanford Markowitz, James KV Willson, Kenneth W Kinzler, Bert Vogelstein, None, Deletion of p16 and p15 Genes in Brain Tumors Cancer Research. ,vol. 54, pp. 6353- 6358 ,(1994)
Ohgaki H, Eibl Rh, Wiestler Od, Newcomb Ew, Yasargil Mg, Kleihues P, p53 Mutations in Nonastrocytic Human Brain Tumors Cancer Research. ,vol. 51, pp. 6202- 6205 ,(1991)
Tetsuro Nishihira, Shozo Mori, Koh Miura, Yusuke Nakamura, Takahisa Aoki, Takahiro Mori, Frequent somatic mutation of the MTS1/CDK4I (multiple tumor suppressor/cyclin-dependent kinase 4 inhibitor) gene in esophageal squamous cell carcinoma. Cancer Research. ,vol. 54, pp. 3396- 3397 ,(1994)
C Cordon-Cardo, Mutations of cell cycle regulators. Biological and clinical implications for human neoplasia. American Journal of Pathology. ,vol. 147, pp. 545- 560 ,(1995)
J. F. Gusella, R. Wellenreuther, A. Von Deimling, O. D. Wiestler, Vijaya Ramesh, D. N. Louis, J. Schramm, A. G. Menon, J. A. Kraus, D. Lenartz, Analysis of the neurofibromatosis 2 gene reveals molecular variants of meningioma. American Journal of Pathology. ,vol. 146, pp. 827- 832 ,(1995)
James F. Gusella, Andreas von Deimling, Mia M. MacCollin, Lee B. Jacoby, Vijaya Ramesh, Katia M. Correa, David N. Louis, Mari Paz Rubio, Analysis of the Neurofibromatosis 2 Gene in Human Ependymomas and Astrocytomas Cancer Research. ,vol. 54, pp. 45- 47 ,(1994)
R Godbout, J He, MJ Allalunis-Turner, rd Rs Day, VP Collins, JR Allen, CD James, CDK4 Amplification Is an Alternative Mechanism to p16 Gene Homozygous Deletion in Glioma Cell Lines Cancer Research. ,vol. 54, pp. 5804- 5807 ,(1994)
Sherr Cj, Shapiro Dn, Valentine M, Khatib Za, Matsushime H, Look At, Coamplification of the CDK4 Gene with MDM2 and GLI in Human Sarcomas Cancer Research. ,vol. 53, pp. 5535- 5541 ,(1993)
Takemi Otsuki, Helen M Clark, Axel Wellmann, Elaine S Jaffe, Mark Raffeld, None, Involvement of CDKN2 (p16INK4A/MTS1) and p15INK4B/MTS2 in Human Leukemias and Lymphomas Cancer Research. ,vol. 55, pp. 1436- 1440 ,(1995)